[go: up one dir, main page]

DK163683A - Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykke dna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet - Google Patents

Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykke dna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet Download PDF

Info

Publication number
DK163683A
DK163683A DK163683A DK163683A DK163683A DK 163683 A DK163683 A DK 163683A DK 163683 A DK163683 A DK 163683A DK 163683 A DK163683 A DK 163683A DK 163683 A DK163683 A DK 163683A
Authority
DK
Denmark
Prior art keywords
human urokinase
medicine
anticricane
coding
protein
Prior art date
Application number
DK163683A
Other languages
English (en)
Other versions
DK173910B1 (da
DK163683D0 (da
Inventor
Herbert Louis Heyneker
William Evan Holmes
Gordon Alan Vehar
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of DK163683D0 publication Critical patent/DK163683D0/da
Publication of DK163683A publication Critical patent/DK163683A/da
Application granted granted Critical
Publication of DK173910B1 publication Critical patent/DK173910B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Vascular Medicine (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Microbiology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK198301636A 1982-04-15 1983-04-14 Ikke-glycosylerede polypeptider, som har en intakt lysin-isoleucin-binding i den position, der svarer til aminosyrerne 158-159 i det native prourokinasemolekyle, og som har tilstrækkeligt af den i fig. 4A og 4B viste aminosyresekvens til, ... DK173910B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US36877382A 1982-04-15 1982-04-15
US36877382 1982-04-15
US47493083A 1983-03-14 1983-03-14
US47493083 1983-03-14

Publications (3)

Publication Number Publication Date
DK163683D0 DK163683D0 (da) 1983-04-14
DK163683A true DK163683A (da) 1983-11-28
DK173910B1 DK173910B1 (da) 2002-02-11

Family

ID=27004326

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198301636A DK173910B1 (da) 1982-04-15 1983-04-14 Ikke-glycosylerede polypeptider, som har en intakt lysin-isoleucin-binding i den position, der svarer til aminosyrerne 158-159 i det native prourokinasemolekyle, og som har tilstrækkeligt af den i fig. 4A og 4B viste aminosyresekvens til, ...

Country Status (20)

Country Link
EP (2) EP0092182B1 (da)
JP (3) JPH0655145B2 (da)
AT (2) ATE112802T1 (da)
AU (1) AU573523B2 (da)
BR (1) BR8301918A (da)
CA (1) CA1341301C (da)
DE (2) DE3382760T2 (da)
DK (1) DK173910B1 (da)
ES (3) ES521418A0 (da)
FI (1) FI88932C (da)
GR (1) GR78180B (da)
HK (1) HK38297A (da)
IE (1) IE64536B1 (da)
IL (2) IL68366A (da)
MY (1) MY102472A (da)
NO (1) NO831317L (da)
NZ (1) NZ203869A (da)
PH (4) PH24783A (da)
PT (1) PT76546B (da)
YU (1) YU45128B (da)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
NZ208612A (en) * 1983-06-24 1991-09-25 Genentech Inc Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations
AU587960B2 (en) * 1983-06-24 1989-09-07 Genentech Inc. Procaryotic carbonyl hydrolases
EP0139447B1 (en) * 1983-09-13 1992-12-30 The Green Cross Corporation A process for preparing urokinase zymogen
EP0154272B1 (en) * 1984-02-27 1992-01-08 Green Cross Corporation Production of human urokinase
JPS61177987A (ja) * 1985-01-31 1986-08-09 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
JPS60180591A (ja) * 1984-02-27 1985-09-14 Green Cross Corp:The ヒトウロキナ−ゼのｄνａ配列，プラスミド，宿主
AU5390286A (en) * 1985-01-25 1986-08-13 Sagami Chemical Research Center Stabilized human prourokinase
JPS61181377A (ja) * 1985-01-25 1986-08-14 Sagami Chem Res Center ヒトウロキナ−ゼ遺伝子
US5219569A (en) * 1985-04-22 1993-06-15 Genentech, Inc. Protease resistant urokinase
US4997766A (en) * 1986-07-11 1991-03-05 American Home Products Corporation Poly-kringle plasminogen activator
US4916071A (en) 1985-08-14 1990-04-10 American Home Products Corporation Poly-kringle plasminogen activator
JPS62149625A (ja) * 1985-12-25 1987-07-03 Green Cross Corp:The 生理活性物質の製造方法
DE3613401A1 (de) * 1986-04-21 1987-12-17 Boehringer Mannheim Gmbh Verfahren zur herstellung von plasminogen-aktivatoren in prokaryonten
NL8601240A (nl) * 1986-05-15 1987-12-01 Leuven Res & Dev Vzw Plasminogeenactivator en trombolytisch geneesmiddel.
GB8623823D0 (en) * 1986-10-03 1986-11-05 Sandoz Ltd Therapeutic lysis of fibrin blood clots
JPS63105675A (ja) * 1986-10-23 1988-05-10 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
ZA879286B (en) 1986-12-16 1988-10-26 Smith Kline Rit New plasminogen activators
JP2983997B2 (ja) * 1987-01-30 1999-11-29 アメリカン・ホーム・プロダクツ・コーポレイション 脱―表皮細胞成長因子プラスミノーゲンアクチベーター
MY103358A (en) * 1987-04-15 1993-06-30 Novartis Ag Process for the production of protiens.
EP0330700B1 (en) * 1987-08-19 1993-12-22 Sagami Chemical Research Center Human prourokinase-like polypeptide
ES2061585T3 (es) * 1987-10-02 1994-12-16 Zymogenetics Inc Señal de secrecion de bar1.
EP0316068A1 (en) * 1987-10-09 1989-05-17 Collaborative Research Inc. Modified low molecular weight plasminogen activator and method of preparation
US4999194A (en) * 1988-01-14 1991-03-12 Collaborative Research, Inc. Two-chain urokinase plasminogen activators for treatment of thrombotic disease
US4920051A (en) * 1988-02-03 1990-04-24 Damon Biotech, Inc. Recovery of urokinase compounds
IE901849A1 (en) 1989-07-19 1991-06-19 Gruenenthal Gmbh Plasmids, their preparation and their use in the manufacture¹of a plasminogen activator
CA2027936C (en) 1989-10-23 2001-07-24 Smithkline Beecham Corporation Cyclic anti-aggregatory peptides
AU661652B2 (en) * 1989-10-24 1995-08-03 Chiron Corporation Infective protein delivery system
DE4101736A1 (de) * 1991-01-22 1992-07-23 Gruenenthal Gmbh Neue als plasminogenaktivatoren einsetzbare polypeptide, dafuer codierende plasmide und verfahren zu deren herstellung und deren verwendung
US5888814A (en) * 1994-06-06 1999-03-30 Chiron Corporation Recombinant host cells encoding TNF proteins
EP1088081B1 (en) * 1998-06-26 2005-03-09 Croptech Development Corporation Production of urokinase in plant-based expression systems
US6833357B2 (en) 2000-06-20 2004-12-21 The Trustees Of The University Of Pennsylvania Compositions and methods for modulating muscle cell and tissue contractility
US20030040095A1 (en) * 2001-03-16 2003-02-27 Achille Arini Method for the production of pharmaceutically active recombinant proteins
ES2400306T3 (es) 2005-10-21 2013-04-09 Catalyst Biosciences, Inc. Proteasas modificadas que inhiben la activación del complemento
EP2402437B1 (en) 2006-07-05 2016-06-01 Catalyst Biosciences, Inc. Protease screening methods and proteases identified thereby

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6642281A (en) * 1979-11-13 1981-06-03 Husain, S.S. Isolation of plasminogen activators useful as therapeutic anddiagnostic agents
US4321363A (en) * 1980-02-21 1982-03-23 Nippon Soda Company Limited Adsorbent for urokinase containing agarose
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
US4506013A (en) * 1980-10-03 1985-03-19 Eli Lilly And Company Stabilizing and selecting recombinant DNA host cells
DE3479520D1 (en) * 1983-11-21 1989-09-28 Ciba Geigy Ag Synthesis of tissue plasminogen activator(tpa) by yeast

Also Published As

Publication number Publication date
AU1352483A (en) 1983-10-20
PT76546A (en) 1983-05-01
FI88932C (fi) 1993-07-26
YU45128B (en) 1992-03-10
ES8602121A1 (es) 1985-12-01
IL68366A0 (en) 1983-07-31
ATE232237T1 (de) 2003-02-15
DK173910B1 (da) 2002-02-11
IL68366A (en) 1990-08-31
DE3382837T2 (de) 2004-01-15
DE3382760T2 (de) 1995-03-02
EP0620279B1 (en) 2003-02-05
IE64536B1 (en) 1995-08-09
PH22461A (en) 1988-09-12
DK163683D0 (da) 1983-04-14
IE830850L (en) 1983-10-15
PH25312A (en) 1991-04-30
MY102472A (en) 1992-06-30
HK38297A (en) 1997-04-04
ATE112802T1 (de) 1994-10-15
ES8500325A1 (es) 1984-11-01
FI831228L (fi) 1983-10-16
JPH0655145B2 (ja) 1994-07-27
PT76546B (en) 1986-03-20
NZ203869A (en) 1987-04-30
IE950235L (en) 1983-10-15
JPS5951300A (ja) 1984-03-24
JP2584192B2 (ja) 1997-02-19
YU86883A (en) 1988-10-31
BR8301918A (pt) 1983-12-20
JPH0824579B2 (ja) 1996-03-13
FI831228A0 (fi) 1983-04-12
EP0620279A1 (en) 1994-10-19
FI88932B (fi) 1993-04-15
GR78180B (da) 1984-09-26
ES533925A0 (es) 1985-12-01
PH25120A (en) 1991-02-19
EP0092182B1 (en) 1994-10-12
JPH07186A (ja) 1995-01-06
AU573523B2 (en) 1988-06-16
DE3382837D1 (de) 2003-03-13
ES521418A0 (es) 1984-11-01
EP0092182A2 (en) 1983-10-26
JPH0530970A (ja) 1993-02-09
ES533924A0 (es) 1985-07-01
EP0092182A3 (en) 1984-07-18
DE3382760D1 (de) 1994-11-17
PH24783A (en) 1990-10-30
CA1341301C (en) 2001-10-09
NO831317L (no) 1983-10-17
ES8506087A1 (es) 1985-07-01
IL83236A0 (en) 1987-12-31

Similar Documents

Publication Publication Date Title
DK163683A (da) Fremstilling af funktionelle humane urokinaseproteiner, dna-sekvens, der koder for et protein omfattende den enzymatiske del af human urokinase, replicerbart udtrykkelsesmedium, der kan udtrykke dna-sekvensen og mikroorganisme eller cellekultur transformeret med mediet
DE3888086D1 (de) Rekombinantes Geflügelpockenvirus, Expressionsvektoren für heterologische Proteine und davon derivierte Geflügelvakzine.
DK215287D0 (da) Dna-sekvenser, der koder for et protein med angiogen virkning, vektorer, vaertsceller og fremgangsmaader til udtrykkelse af proteinet, samt laegemidler indeholdende dette
DK120387A (da) Hybridinterferoner, deres anvendelse som laegemiddel og mellemprodukter til fremstilling af antistoffer og disses anvendelse samt fremgangsmaade til deres fremstilling
DE68924162D1 (de) Stressproteine und verwendungen dafür.
BR1101088A (pt) Proteìna g do vìrus sincicial respiratório não glicosilada isolada e substancialmente pura
DK666888A (da) Human vaevsfaktor-relaterende dna-segmenter, polypeptider og antistoffer
DK175843B1 (da) Polypeptider af overfladeaktive alvelolarproteiner (ASP), farmaceutisk sammensætning indeholdende polypeptidet, DNA-ekspressionssystem der koder for polypeptidet, samt fremgangsmåde til fremstilling af polypeptider med ASP-aktivitet
DE3751727D1 (de) Polypeptide zur verwendung bei der diagnose von mycoplasmainfektionen bei schweinen, sowie rekombinant-dns-verfahren zur herstellung derselben
FI885025A0 (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DK569886A (da) Fremstilling af human somatomedin c
FI934079L (fi) Menetelmä fuusioproteiinin valmistamiseksi
IT8349430A0 (it) Metodo per la produzione di proteine antigeniche specifiche del virusdell'epatite umana a, loro utilizzazione per la produzione di preparazioni farmaceutiche e mezzi diagnostici
DK164283C (da) Polypeptid med cystatin c aktivitet, dna-sekvens til udtrykkelse af 3-des-oh-cystatin c eller en modifikation deraf, fremgangsmaade til fremstilling af 3-des-hydroxy-cystatin c eller en modifikation deraf, plasmid og mikroorganisme til udoevelse af fremgangsmaaden og anvendelse af 3-des-oh-cystatin c eller en modifikation deraf til fremstilling af et terapeutisk praeparat

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired